Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Cash & Current Investments: 2013-2024

Historic Cash & Current Investments for KalVista Pharmaceuticals (KALV) over the last 9 years, with Apr 2024 value amounting to $210.4 million.

  • KalVista Pharmaceuticals' Cash & Current Investments was N/A to $268.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $788.8 million, marking a year-over-year change of. This contributed to the annual value of $210.4 million for FY2024, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Cash & Current Investments stood at $210.4 million for FY2024, which was up 210.72% from $67.7 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Cash & Current Investments registered a high of $210.4 million during FY2024, and its lowest value of $67.7 million during FY2020.
  • In the last 1 years, KalVista Pharmaceuticals' Cash & Current Investments had a median value of $210.4 million in 2024 and averaged $210.4 million.
  • Data for KalVista Pharmaceuticals' Cash & Current Investments shows a maximum YoY tumbled of 32.83% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Cash & Current Investments stood at $67.7 million in 2020, then followed by $210.4 million in 2024.